Home Tools
Log in
Cart

Ligands for Target Protein for PROTAC

Cat. No. Product name CAS No. Purity Chemical Structure
T12551 PROTAC BRD4 ligand-1 2313230-51-0 98%
PROTAC BRD4 ligand-1 is a ligand for BRD4 for Protac GNE-987 and an inhibitor of BET.
T10879 CPI-0610 carboxylic acid 1380089-81-5 98%
CPI-0610 carboxylic acid is an effective and selective small molecule inhibitor of bromine domain and outer end (BET) protein as a ligand of PROTAC target protei...
T12186 Navitoclax-piperazine 2143096-93-7 98%
Navitoclax-piperazine is an inhibitor of B-cell lymphoma extra large (BCL-XL).
T1835 Ibrutinib 936563-96-1 98%
Ibrutinib is an irreversible inhibitor of BTK (IC50: 0.5 nM) that selectively blocks B cell activation.
T19301 DUPA 302941-52-2 98%
DUPA selectively delivers cytotoxic drugs to prostate cancer cells [1][2], belonging to the glutamate class, as a targeted part of drug coupling.
T2110 (+)-JQ-1 1268524-70-4 98%
(+)-JQ1 is a BET bromodomain inhibitor (IC50: 77 nM/33 nM for BRD4 (1/2)).
T5480 BI-4464 1227948-02-8 98%
BI-4464 is a highly selective ATP competitive inhibitor of PTK2/FAK, with an IC50 of 17 nM. A PTK2 ligand for PROTAC
T10359 AR antagonist 1 1818885-54-9 98%
AR antagonist 1 is a potent antagonist of the androgen receptor. It binds to E3 ligase ligands with weak binding affinities to VHL protein in the synthesis of PR...
T13954 UNC6852 2688842-08-0 98%
UNC6852 contains an EED ligand (IC50 = 247 nM) and a von Hippel-Lindau ligand and is a selective polycomb repressive complex 2 (PRC2) degrader based on PROTAC.
T18595 Dasatinib carbaldehyde 2112837-79-1 98%
Dasatinib carbaldehyde is based on Dasatinib which is an ABL inhibitor, binds to the IAP ligand via a linker, and forms SNIPER [1].
T2066 Quizartinib 950769-58-1 98%
Quizartinib is an inhibitor of FLT3 (Kd: 1.6 nM) and demonstrates high selectivity for FLT3 when tested against a panel of 227 additional kinases.
PROTAC BRD4 ligand-1
T12551
PROTAC BRD4 ligand-1 is a ligand for BRD4 for Protac GNE-987 and an inhibitor of BET.
CPI-0610 carboxylic acid
T10879
CPI-0610 carboxylic acid is an effective and selective small molecule inhibitor of bromine domain and outer end (BET) protein as a ligand of PROTAC target protei...
Navitoclax-piperazine
T12186
Navitoclax-piperazine is an inhibitor of B-cell lymphoma extra large (BCL-XL).
Ibrutinib
T1835
Ibrutinib is an irreversible inhibitor of BTK (IC50: 0.5 nM) that selectively blocks B cell activation.
DUPA
T19301
DUPA selectively delivers cytotoxic drugs to prostate cancer cells [1][2], belonging to the glutamate class, as a targeted part of drug coupling.
(+)-JQ-1
T2110
(+)-JQ1 is a BET bromodomain inhibitor (IC50: 77 nM/33 nM for BRD4 (1/2)).
BI-4464
T5480
BI-4464 is a highly selective ATP competitive inhibitor of PTK2/FAK, with an IC50 of 17 nM. A PTK2 ligand for PROTAC
AR antagonist 1
T10359
AR antagonist 1 is a potent antagonist of the androgen receptor. It binds to E3 ligase ligands with weak binding affinities to VHL protein in the synthesis of PR...
UNC6852
T13954
UNC6852 contains an EED ligand (IC50 = 247 nM) and a von Hippel-Lindau ligand and is a selective polycomb repressive complex 2 (PRC2) degrader based on PROTAC.
Dasatinib carbaldehyde
T18595
Dasatinib carbaldehyde is based on Dasatinib which is an ABL inhibitor, binds to the IAP ligand via a linker, and forms SNIPER [1].
Quizartinib
T2066
Quizartinib is an inhibitor of FLT3 (Kd: 1.6 nM) and demonstrates high selectivity for FLT3 when tested against a panel of 227 additional kinases.